- Home
- RDZN vs MNOV Comparison
RDZN vs MNOV Comparison
Compare RDZN & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- MNOV
- Stock Information
- Founded
- RDZN 2015
- MNOV 2000
- Country
- RDZN United States
- MNOV United States
- Employees
- RDZN 308
- MNOV N/A
- Industry
- RDZN Blank Checks
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- MNOV Health Care
- Exchange
- RDZN Nasdaq
- MNOV Nasdaq
- Market Cap
- RDZN 74.5M
- MNOV 65.7M
- IPO Year
- RDZN N/A
- MNOV 2005
- Fundamental
- Price
- RDZN $0.99
- MNOV $1.23
- Analyst Decision
- RDZN Strong Buy
- MNOV Strong Buy
- Analyst Count
- RDZN 2
- MNOV 2
- Target Price
- RDZN $5.00
- MNOV $7.00
- AVG Volume (30 Days)
- RDZN 214.0K
- MNOV 64.1K
- Earning Date
- RDZN 11-12-2025
- MNOV 11-12-2025
- Dividend Yield
- RDZN N/A
- MNOV N/A
- EPS Growth
- RDZN N/A
- MNOV N/A
- EPS
- RDZN N/A
- MNOV N/A
- Revenue
- RDZN $46,230,126.00
- MNOV $134,599.00
- Revenue This Year
- RDZN $38.45
- MNOV N/A
- Revenue Next Year
- RDZN $66.38
- MNOV N/A
- P/E Ratio
- RDZN N/A
- MNOV N/A
- Revenue Growth
- RDZN N/A
- MNOV N/A
- 52 Week Low
- RDZN $0.68
- MNOV $1.13
- 52 Week High
- RDZN $2.99
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- RDZN 45.76
- MNOV 37.77
- Support Level
- RDZN $0.93
- MNOV $1.25
- Resistance Level
- RDZN $1.00
- MNOV $1.38
- Average True Range (ATR)
- RDZN 0.06
- MNOV 0.05
- MACD
- RDZN 0.00
- MNOV -0.01
- Stochastic Oscillator
- RDZN 55.63
- MNOV 0.00
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.